Crossmark

Effects of different kinds of anti-Alzheimer’s disease drugs on cognitive improvement: protocol for a systematic review and network meta-analysis of phase III clinical trials

Crossref DOI link: https://doi.org/10.1186/s13643-022-01964-x

Published Online: 2022-05-03

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lyu, Diyang http://orcid.org/0000-0001-5677-2382
Gong, Min

Zhang, Yong

Lyu, Xuanxin
Funding

Funding for this research was provided by:

The Scientific Research Fund of Beijing Rehabilitation Hospital, Capital Medical University (NA)

Young Scientists Fund (81804160)

The Young Talent Program of Dongzhimen Hospital (DZMYS-201711)
License Information

Text and Data Mining valid from 2022-05-03

Version of Record valid from 2022-05-03
More Information

Article History

Received: 11 May 2021

Accepted: 21 April 2022

First Online: 3 May 2022

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below